CIENCIASMEDICASNEWS: Fogarty International Center: Funding News from Fogarty Int'l Center at NIH

viernes, 10 de abril de 2015

Fogarty International Center: Funding News from Fogarty Int'l Center at NIH

Fogarty International Center

Funding news for global health researchers and partners from Fogarty at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp) (PAR-15-155)
Application Receipt/Submission Date(s): June 08, 2015

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

HIV Vaccine Research and Design (HIVRAD) Program (P01) (PAR-15-164)
Application Receipt/Submission Date(s): July 15, 2015; July 15, 2016; July 14, 2017
Oral Immune System Plasticity in Chronic HIV Infection Under Treatment and Oral Co-Infections (R01) (RFA-DE-16-002)
Application Receipt Date(s): October 29, 2015
Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01) (PA-15-159)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Exploratory/Developmental Clinical Research Grants in Obesity (R21) (PA-15-163)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21) (PAR-15-161) and Urologic Disorders (R21) (PAR-15-162)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21) (PA-15-169)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Alzheimer's Drug-Development Program (U01) (PAR-15-174)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01) (PAR-15-175)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Request for Proposals (RFP) Notice: Population Assessment of Tobacco and Health (PATH) Study (NOT-DA-15-060)
Mechanisms of Immune Protection from TB among HIV-infected Individuals (R01) (RFA-AI-14-072)
Application Receipt Date(s): July 22, 2015
Research Answers to NCI's Provocative Questions (R01) (RFA-CA-15-008) and(R21) (RFA-CA-15-009)
Application Receipt Date(s): June 29, 2015; October 29, 2015; June 29, 2016; October 28, 2016
Limited Competition: Revisions to Add Phase 2 Clinical Trials Program to Experimental Therapeutics Clinical Trials Network (ETCTN) (UM1) (RFA-CA-15-501)
Application Receipt Date(s): June 19, 2015
Educating Groups Influencing Generic Drug Use (U01) (RFA-FD-15-013)
Application Receipt Date(s): June 03, 2015
Methodologies to Enhance Understanding of HIV Associated Social Determinants (R01) (RFA-MH-16-200) and (R21) (RFA-MH-16-205)
Application Receipt Date(s): August 19, 2015
Psychiatric Gene Networks: Solving the Molecular Puzzle of Psychiatric Disorders (R01) (RFA-MH-16-300) and (Collaborative R01) (RFA-MH-16-310)
Application Receipt Date(s): June 29, 2015
Lifespan Human Connectome Project: Baby Connectome (U01) (RFA-MH-16-160)
Application Receipt Date(s): September 03, 2015
Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R33) (RFA-MH-16-400) and (R21/R33) (RFA-MH-16-405)
Application Receipt Date(s): June 15, 2015; October 14, 2015; February 17, 2016; June 15, 2016; October 14, 2016
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34) (RFA-MH-16-410)
Application Receipt Date(s): June 15, 2015; October 14, 2015; February 17, 2016; June 15, 2016; October 14, 2016
Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions (Collaborative R01) (RFA-MH-16-415) and (R01) (RFA-MH-16-420)
Application Receipt Date(s): June 15, 2015; October 14, 2015; February 17, 2016; June 15, 2016; October 14, 2016
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01) (RFA-MH-16-425)
Application Receipt Date(s): June 15, 2015; October 14, 2015; February 17, 2016; June 15, 2016; October 14, 2016
Diet and Physical Activity Assessment Methodology (R01) (PAR-15-170) and(R21) (PAR-15-171)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
New Directions in Hematology Research (SHINE-II) (R01) (PAS-15-168)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
NIAMS Clinical Trial Implementation Cooperative Agreement (U01) (PAR-15-165) and (U34) (PAR-15-166)
Application Receipt/Submission Date(s): July 1, 2015; November 2, 2015; March 1, 2016
Pediatric Research using Integrated Sensor Monitoring Systems (PRISMS):
Sensor Development Projects for Asthma (U01) (RFA-EB-15-002)Informatics Platform Technologies for Asthma (U54) (RFA-EB-15-003)Data and Software Coordination and Integration Center (DSCIC) (U24) (RFA-EB-15-004)
Application Receipt Date(s): June 01, 2015
Genome Sequencing Program Coordinating Center (U24) (RFA-HG-15-019)
Application Receipt Date(s): May 29, 2015
Cancer Research Education Grants Program: Courses for Skills Development(R25) (PAR-15-151) and Research Experiences (R25) (PAR-15-152)
Application Receipt/Submission Date(s): Multiple dates, see announcement.

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (UT2) (PAR-15-153) and(U44) (PAR-15-154)
Application Receipt/Submission Date(s): June 11, 2015, December 9, 2015, May 10, 2016, December 9, 2016
Methods Development in Natural Products Chemistry (R43/R44) (RFA-AT-16-003) and (R41/R42) (RFA-AT-16-004)
Application Receipt Date(s): August 05, 2015

Funding News

NIH funding news that may be relevant to global health researchers.

Requests for Information (RFI):

Optimizing Funding Policies and Other Strategies to Improve the Impact and Sustainability of Biomedical Research (NOT-OD-15-084)
Proposed Funding Priorities for Neuroscience Research, Input on High Impact and Cross-Cutting Opportunities (NIH Neuroscience Blueprint) (NOT-NS-15-020)
NHLBI Strategic Visioning - Developing the Research Priorities for the Next Decade (NOT-HL-15-252)
Input on National Cancer Institute Metadata Repository and Services (NOT-CA-15-019)
Data Informatics Needs and Challenges for Enabling SPARC (Stimulating Peripheral Activity to Relieve Conditions) (NOT-RM-15-010)

Publication of the Revised NIH Grants Policy Statement (Rev. 3/31/2015) (NOT-OD-15-087)
Reminder: NIH and AHRQ Biosketch Requirements for Due Dates On or After May 25, 2015 (NOT-OD-15-085)
Notice for Use of Cloud Computing Services for Storage and Analysis of Controlled-Access Data Subject to the NIH Genomic Data Sharing (GDS) Policy (NOT-OD-15-086)
NCCIH Policy for Submission of R15 Applications Containing Clinical Trials (NOT-AT-15-005)
Notice of an Update to the Eligibility Information in PAR-15-131 "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11)" (NOT-AI-15-030)
Notice of Information: Announcement of Q&As for PAR-15-131 "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11)" (NOT-AI-15-031)
Notice of Availability of Additional Marijuana Strains through NIDA's Drug Supply Program (NOT-DA-15-064)
Notice of Extension of the Response Date for NOT-AR-15 -010 "Request for Information (RFI): Core Centers for Clinical Research (CCCR)" (NOT-AR-15-017)
Notice of an Extension of Expiration Date for Research to Advance Vaccine Safety PA-12-037 (R01) (NOT-AI-15-027) and PA-12-038 (R21) (NOT-AI-15-028)
Notice of Change in Age Range to Include Young Adults up to 25 years of age in PA-15-036 "Research Aimed at Novel Behavioral Targets to Improve Adolescent Substance Abuse Treatment and Prevention Interventions (R01)" (NOT-DA-15-062)
Notice of Clarification of Letter of Intent (LOI) Due Date(s) for NIDA PA-15-099 "Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)" (NOT-DA-15-063)
Notice of Clarification for RFA-HD-15-034 Developing Paradigm-Shifting Innovations for in vivo Human Placental Assessment in Response to Environmental Influences (U01) (NOT-HD-15-014)
Notice of Change to Award Information Regarding Allowable Requested Direct Costs in PAR-13-316 "NHLBI Program Project Applications (P01)" (NOT-HL-15-256)
Notice of National Heart, Lung, and Blood Institute (NHLBI) Participation in PAR-15-085 "Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (U01)" (NOT-HL-15-257)
Notice of Correction of the First Advisory Council Review Date for PAR-15-121 "BRAIN Initiative: Optimization of Novel Tools and Technologies for Neuroscience Research (R44)" (NOT-NS-15-017)
Notice of Correction to the Budget Instructions for Innovation Grants to Nurture Initial Translational Efforts (IGNITE):
PAR-15-070 Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33)" (NOT-NS-15-018)
PAR-15-071 Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33)" (NOT-NS-15-019)
Notice To Announce Continued Funding and Updated Research Objectives for PAS-13-031 "Stimulating Hematology Investigation: New Endeavors (SHINE) (R01)" (NOT-DK-15-011)
Notice of Change to Application Due Dates and Expiration Date:
PAR-13-202 Enhancing Post-Market Surveillance through Developing Registries for Medical Device Epidemiology(U01) (NOT-FD-15-003)
PAR-13-232 Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01) (NOT-FD-15-004)
Notice of Termination of RFA-AI-14-045 "Hepatitis C Virus Cooperative Research Centers: Immunity to HCV Infection (U19)" (NOT-AI-15-026)